Renal aging: Causes and consequences

Journal of the American Society of Nephrology

Volumn 28, Issue 2, 2017, Pages 407-420

  O'Sullivan, Eoin D ^a   Hughes, Jeremy ^a,b   Ferenbach, David A ^a,b,c  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; KLOTHO PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; WNT PROTEIN;

AGING; CELL CYCLE PROGRESSION; CLINICAL FEATURE; EPIGENETICS; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXIA; INFLAMMATION; KIDNEY; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; META ANALYSIS (TOPIC); NEPHROSCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; REVIEW; SIGNAL TRANSDUCTION; TELOMERE; TISSUE DEGENERATION; TISSUE REPAIR; CELL CYCLE; CELL HYPOXIA; CYTOLOGY; FORECASTING; MALE; MEDICAL RESEARCH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; TRENDS;

AGING; BIOMEDICAL RESEARCH; CELL CYCLE; CELL HYPOXIA; FORECASTING; HUMANS; KIDNEY; MALE; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

EID: 85014954854     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015121308     Document Type: Review

References (201)

1. Centers for Disease Control and Prevention: The State of Aging and Healthy in America, Atlanta, GA, Createspace Independent Publisher, 2013
2. European Commission: The 2015 ageing report. Eur Econ 3: 424, 2015
3. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG: The aging kidney. Kidney Int 74: 710-720, 2008
4. Newbold KM, Sandison A, Howie AJ: Comparison of size of juxtamedullary and outer cortical glomeruli in normal adult kidney. Virchows Arch A Pathol Anat Histopathol 420: 127-129, 1992
5. Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232: 194-201, 1992
6. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD: The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152: 561-567, 2010
7. ChanKW, Leung CY, Chan CW: Age-related glomerular sclerosis: Baseline values in Hong Kong. Pathology 22: 177-180, 1990
8. Denic A, Alexander MP, Kaushik V, Lerman LO, Lieske JC, Stegall MD, Larson JJ, Kremers WK, Vrtiska TJ, Chakkera HA, Poggio ED, Rule AD: Detection and clinical patterns of nephron hypertrophy and nephrosclerosis among apparently healthy adults. Am J Kidney Dis 68: 58-67, 2016
9. Rule AD, Cornell LD, Poggio ED: Senile nephrosclerosis-does it explain the decline in glomerular filtration rate with aging?. Nephron Physiol 119[Suppl l]: 6-11, 2011
10. Meyrier A: Nephrosclerosis: A term in quest of a disease. Nephron 129: 276-282, 2015
11. Meyrier A: Nephrosclerosis: Update on a centenarian. Nephrol Dial Transplant 30: 1833-1841, 2015
12. Ferenbach DA, Bonventre JV: Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol 11: 264-276, 2015
13. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW: The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 31: 155-163, 1976
14. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285, 1985
15. Baba M, Shimbo T, Horio M, Ando M, Yasuda Y, Komatsu Y, Masuda K, Matsuo S, Maruyama S: Longitudinal study of the decline in renal function in healthy subjects. PLoS One 10: E0129036, 2015
16. Cohen E, Nardi Y, Krause I, Goldberg E, Milo G, Garty M, Krause I: A longitudinal assessment of the natural rate of decline in renal function with age. J Nephrol 27: 635-641, 2014
17. Wetzels JFM, Kiemeney LALM, Swinkels DW, Willems HL, den Heijer M: Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen biomedical study. Kidney Int 72: 632-637, 2007
18. Sarnak MJ, Poindexter A, Wang S-R, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS: Serum C-reactive protein and leptin as predictors of kidney disease progression in the modification of diet in renal disease study. Kidney Int 62: 2208-2215, 2002
19. Imai E, HorioM, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S: Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res 31: 433-441, 2008
20. Hollenberg NK, Rivera A, Meinking T, Martinez G, McCullough M, Passan D, Preston M, Taplin D, Vicaria-Clement M: Age, renal perfusion and function in islanddwelling indigenous Kuna Amerinds of Panama. Nephron 82: 131-138, 1999
21. Sands JM: Urine concentrating and diluting ability during aging. J Gerontol A Biol Sci Med Sci 67: 1352-1357, 2012
22. Mimran A, Ribstein J, Jover B: Aging and sodium homeostasis. Kidney Int Suppl 37: S107-S113, 1992
23. Michelis MF: Hyperkalemia in the elderly. AmJ Kidney Dis 16: 296-299, 1990
24. Mc Greevy C, Horan J, Jones D, Biswas K, O'Meara YM, Mulkerrin EC: A study of tubular potassium secretory capacity in older patients with hyperkalaemia. J Nutr Health Aging 12: 152-155, 2008
25. Musso C, Liakopoulos V, Stefanidis I, De Miguel R, Imperiali N, Algranati L: Correlation between creatinine clearance and transtubular potassium concentration gradient in old people and chronic renal disease patients. Saudi J KidneyDis Transpl 18: 551-555, 2007
26. Takazakura E, Sawabu N, Handa A, Takada A, Shinoda A, Takeuchi J: Intrarenal vascular changes with age and disease. Kidney Int 2: 224-230, 1972
27. Hajduczok G, Chapleau MW, Johnson SL, Abboud FM: Increase in sympathetic activity with age. I. Role of impairment of arterial baroreflexes. Am J Physiol 260: H1113-H1120, 1991
28. Jerkic M, Vojvodic S, López-Novoa JM: The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. Int Urol Nephrol 32: 539-547, 2001
29. Mulkerrin EC, Brain A, Hampton D, Penney MD, Sykes DA, Williams JD, Coles GA, Woodhouse KW: Reduced renal hemodynamic response to atrial natriuretic peptide in elderly volunteers. Am J Kidney Dis 22: 538-544, 1993
30. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G, Natale G, Andreucci M, Memoli B, De Nicola L, Conte G: Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 59: 1052-1058, 2001
31. Fliser D, Zeier M, Nowack R, Ritz E: Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 3: 1371-1377, 1993
32. Sverdlov AL, Ngo DTM, ChanWPA, Chirkov YY, Horowitz JD: Aging of the nitric oxide system: Are we as old as our NO?. J Am Heart Assoc 3: E000973, 2014
33. Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D: Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107: 1891-1895, 2003
34. Ahmed SB, Fisher NDL, Hollenberg NK: Gender and the renal nitric oxide synthase system in healthy humans. Clin J Am Soc Nephrol 2: 926-931, 2007
35. Ferenbach DA, Nkejabega NCJ, McKay J, Choudhary AK, Vernon MA, Beesley MF, Clay S, Conway BC, Marson LP, Kluth DC, Hughes J: The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice. Kidney Int 79: 966-976, 2011
36. Nath KA, Grande JP, Farrugia G, Croatt AJ, Belcher JD, Hebbel RP, Vercellotti GM, Katusic ZS: Age sensitizes the kidney to heme protein-induced acute kidney injury. AmJ Physiol Renal Physiol 304: F317-F325, 2013
37. Maddens B, Vandendriessche B, Demon D, Vanholder R, Chiers K, Cauwels A, Meyer E: Severity of sepsis-induced acute kidney injury in a novel mouse model is age dependent. Crit Care Med 40: 2638-2646, 2012
38. Clements ME, Chaber CJ, Ledbetter SR, Zuk A: Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One 8: E70464, 2013
39. Kuro-oM, MatsumuraY, Aizawa H, KawaguchiH, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of themouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997
40. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113: 561-568, 2004
41. Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B: Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D mediated process. FASEB J 20: 720-722, 2006
42. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M: Suppression of aging in mice by the hormone Klotho. Science 309: 1829-1833, 2005
43. John GB, Cheng C-Y, Kuro-o M: Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis 58: 127-134, 2011
44. Kuro-oM: Klotho as a regulator of oxidative stress and senescence. Biol Chem 389: 233-241, 2008
45. Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M: Intracellular signaling of the aging suppressor protein Klotho. Curr Mol Med 15: 27-37, 2015
46. Yang H, Fogo AB: Cell senescence in the aging kidney. J Am Soc Nephrol 21: 1436-1439, 2010
47. Liu Q-F, Ye J-M, Deng Z-Y, Yu L-X, Sun Q, Li S-S: Ameliorating effect of Klotho on endoplasmic reticulum stress and renal fibrosis induced by unilateral ureteral obstruction. Iran J Kidney Dis 9: 291-297, 2015
48. Kuro-oM: Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 15: 437-441, 2006
49. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y: Loss of Klotho contributes to kidney injury by derepression ofWnt/b-catenin signaling. J Am Soc Nephrol 24: 771-785, 2013
50. Zhang X, Chen X, Hong Q, Lin H, Zhu H, Liu Q, Wang J, Xie Y, Shang X, Shi S, Lu Y, Yin Z: TIMP-1 promotes age-related renal fibrosis through upregulating ICAM-1 in human TIMP-1 transgenic mice. J Gerontol A Biol Sci Med Sci 61: 1130-1143, 2006
51. Tan RJ, Zhou D, Zhou L, Liu Y: Wnt/b-catenin signaling and kidney fibrosis. Kidney Int Suppl (2011) 4: 84-90, 2014
52. Bian A, Neyra JA, Zhan M, Hu MC: Klotho, stem cells, and aging. Clin Interv Aging 10: 1233-1243, 2015
53. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807-810, 2007
54. Maarouf OH, Aravamudhan A, Rangarajan D, Kusaba T, Zhang V, Welborn J, Gauvin D, Hou X, Kramann R, Humphreys BD: ParacrineWnt1 drives interstitial fibrosis without inflammation by tubulointerstitial cross-talk. J Am Soc Nephrol 27: 781-790, 2016
55. Hao S, HeW, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M, Liu Y: Targeted inhibition of b-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642-1653, 2011
56. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011
57. Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, Hou FF, Kahn M, Liu Y:Multiple genes of the renin-angiotensin system are novel targets of Wnt/b-catenin signaling. J AmSocNephrol 26: 107-120, 2015
58. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, TakanashiM, Irukayama-Tomobe Y, Sakai S, Ohmori H, MatsudaM, Yamaguchi I: Aginginduced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol 283: H1750-H1760, 2002
59. Wang P, Li B, Cai G, HuangM, Jiang L, Pu J, Li L, Wu Q, Zuo L, Wang Q, Zhou P: Activation of PPAR-g by pioglitazone attenuates oxidative stress in aging rat cerebral arteries through upregulating UCP2. J Cardiovasc Pharmacol 64: 497-506, 2014
60. Zhang H, Li Y, Fan Y, Wu J, Zhao B, Guan Y, Chien S, Wang N: Klotho is a target gene of PPAR-gamma. Kidney Int 74: 732-739, 2008
61. Zhang R, Zheng F: PPAR-gamma and aging: One link through klotho?. Kidney Int 74: 702-704, 2008
62. Sung B, Park S, Yu BP, Chung HY: Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci 59: 997-1006, 2004
63. Briganti S, Flori E, Bellei B, Picardo M: Modulation of PPARg provides new insights in a stress induced premature senescence model. PLoS One 9: E104045, 2014
64. Lim HA, Lee EK, Kim JM, Park MH, Kim DH, Choi YJ, Ha YM, Yoon J-H, Choi JS, Yu BP, Chung HY: PPARg activation by baicalin suppresses NF-kB-mediated inflammation in aged rat kidney. Biogerontology 13: 133-145, 2012
65. Sangaralingham SJ, Wang BH, Huang L, Kumfu S, Ichiki T, Krum H, Burnett JC Jr. : Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen. Peptides 76: 108-114, 2016
66. Fogo AB: The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 35: 179-188, 2000
67. Vajapey R, Rini D, Walston J, Abadir P: The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front Physiol 5: 439, 2014
68. Benigni A, Cassis P, Remuzzi G: Angiotensin II revisited: New roles in inflammation, immunology and aging. EMBO Mol Med 2: 247-257, 2010
69. Cuevas CA, Gonzalez AA, Inestrosa NC, Vio CP, Prieto MC: Angiotensin II increases fibronectin and collagen I through the b-catenindependent signaling in mouse collecting duct cells. Am J Physiol Renal Physiol 308: F358-F365, 2015
70. Ruiz-Torres MP, Bosch RJ, O'Valle F, Del Moral RG, Ramírez C, Masseroli M, Pérez-Caballero C, Iglesias MC, Rodríguez-Puyol M, Rodríguez-Puyol D: Age-related increase in expression of TGF-beta1 in the rat kidney: Relationship to morphologic changes. J Am Soc Nephrol 9: 782-791, 1998
71. Cruz CI, Ruiz-Torres P, del Moral RG, Rodríguez-Puyol M, Rodríguez-Puyol D: Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol Renal Physiol 278: F122-F129, 2000
72. de Cavanagh EMV, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, FragaCG: Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003
73. VlassaraH, TorreggianiM, Post JB, Zheng F, Uribarri J, Striker GE: Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney Int Suppl 114: S3-S11, 2009
74. Simão S, Gomes P, Pinto V, Silva E, Amaral JS, Igreja B, Afonso J, SerrãoMP, PinhoMJ, Soares-da-Silva P: Age-related changes in renal expression of oxidant and antioxidant enzymes and oxidative stress markers in male SHR and WKY rats. Exp Gerontol 46: 468-474, 2011
75. Miyazawa M, Ishii T, Yasuda K, Noda S, Onouchi H, Hartman PS, Ishii N: The role of mitochondrial superoxide anion (O2(-)) on physiological aging in C57BL/6J mice. J Radiat Res (Tokyo) 50: 73-83, 2009
76. Nath KA: The role of Sirt1 in renal rejuvenation and resistance to stress. J Clin Invest 120: 1026-1028, 2010
77. Akçetin Z, Erdemli G, Brömme HJ: Experimental study showing a diminished cytosolic antioxidative capacity in kidneys of aged rats. Urol Int 64: 70-73, 2000
78. Martin R, Fitzl G, Mozet C, Martin H, Welt K, Wieland E: Effect of age and hypoxia/reoxygenation on mRNA expression of antioxidative enzymes in rat liver and kidneys. Exp Gerontol 37: 1481-1487, 2002
79. Qiao X, Chen X, Wu D, Ding R, Wang J, Hong Q, Shi S, Li J, Xie Y, Lu Y, Wang Z: Mitochondrial pathway is responsible for aging-related increase of tubular cell apoptosis in renal ischemia/reperfusion injury. J Gerontol A Biol Sci Med Sci 60: 830-839, 2005
80. Small DM, Bennett NC, Roy S, Gabrielli BG, Johnson DW, Gobe GC: Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease. Nephron Exp Nephrol 122: 123-130, 2012
81. Kitada M, Kume S, Takeda-Watanabe A, Kanasaki K, Koya D: Sirtuins and renal diseases: Relationship with aging and diabetic nephropathy. Clin Sci (Lond) 124: 153-164, 2013
82. Yeung F, Hoberg JE, RamseyCS, KellerMD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004
83. Kume S, Uzu T, Horiike K, Chin-Kanasaki M, Isshiki K, Araki S, Sugimoto T, Haneda M, Kashiwagi A, Koya D: Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependentmitochondrial autophagy in mouse aged kidney. J Clin Invest 120: 1043-1055, 2010
84. HeW, Wang Y, Zhang M-Z, You L, Davis LS, Fan H, Yang H-C, Fogo AB, Zent R, Harris RC, Breyer MD, Hao C-M: Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120: 1056-1068, 2010
85. Sauve AA, Wolberger C, Schramm VL, Boeke JD: The biochemistry of sirtuins. Annu Rev Biochem 75: 435-465, 2006
86. Longo VD, Kennedy BK: Sirtuins in aging and age-related disease. Cell 126: 257-268, 2006
87. Radak Z, Koltai E, Taylor AW, Higuchi M, Kumagai S, Ohno H, Goto S, Boldogh I: Redox-regulating sirtuins in aging, caloric restriction, and exercise. Free Radic Biol Med 58: 87-97, 2013
88. Park S, Mori R, Shimokawa I: Do sirtuins promote mammalian longevity?. A critical review on its relevance to the longevity effect induced by calorie restriction.Mol Cells 35: 474-480, 2013
89. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, SalioM, Conti S, RottoliD, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G: Disruption of the Ang II type 1 receptor promotes longevity inmice. J ClinInvest 119: 524-530, 2009
90. Schmitt R, Marlier A, Cantley LG: Zag expression during aging suppresses proliferation after kidney injury. J AmSoc Nephrol 19: 2375-2383, 2008
91. Sörensen-Zender I, Bhayana S, Susnik N, Rolli V, Batkai S, Baisantry A, Bahram S, Sen P, Teng B, Lindner R, Schiffer M, Thum T, Melk A, Haller H, Schmitt R: Zinc-a2-Glycoprotein exerts antifibrotic effects in kidney and heart. J Am Soc Nephrol 26: 2659-2668, 2015
92. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543, 2010
93. Jun J-I, Lau LF: The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12: 676-685, 2010
94. van Deursen JM: The role of senescent cells in ageing. Nature 509: 439-446, 2014
95. Yang G, Rosen DG, Zhang Z, Bast RC Jr., Mills GB, Colacino JA, Mercado-Uribe I, Liu J: The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 103: 16472-16477, 2006
96. Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS: Oncogene-induced senescence relayed by an interleukindependent inflammatory network. Cell 133: 1019-1031, 2008
97. Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, Brambilla E, Brambilla C, Serrano M, Harris CC, Pedeux R: WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res 69: 9183-9191, 2009
98. Braun H, Schmidt BMW, Raiss M, Baisantry A, Mircea-Constantin D, Wang S, GrossM-L, Serrano M, Schmitt R, Melk A: Cellular senescence limits regenerative capacity and allograft survival. J AmSoc Nephrol 23: 1467-1473, 2012
99. Chkhotua AB, Abendroth D, Froeba G, Schelzig H: Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: Differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int 19: 72-77, 2006
100. Lee DH, Wolstein JM, Pudasaini B, Plotkin M: INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury. Am J Physiol Renal Physiol 302: F183-F191, 2012
101. Wolstein JM, Lee DH, Michaud J, Buot V, Stefanchik B, Plotkin MD: INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction. Am J Physiol Renal Physiol 299: F1486-F1495, 2010
102. Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, VerzosaGC, Pezeshki A, Khazaie K, Miller JD, vanDeursen JM:Naturally occurring p16-positive cells shorten healthy lifespan. Nature 530: 184-189, 2016
103. Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J, Janakiraman K, Sharpless NE, Ding S, Feng W, Luo Y, Wang X, Aykin-Burns N, Krager K, Ponnappan U, Hauer-Jensen M, Meng A, Zhou D: Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med 22: 78-83, 2016
104. Aubert G, Lansdorp PM: Telomeres and aging. Physiol Rev 88: 557-579, 2008
105. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198, 2003
106. Mikhelson VM, Gamaley IA: Telomere shortening is a sole mechanism of aging in mammals. Curr Aging Sci 5: 203-208, 2012
107. Wills LP, Schnellmann RG: Telomeres and telomerase in renal health. J Am Soc Nephrol 22: 39-41, 2011
108. Westhoff JH, Schildhorn C, Jacobi C, Hömme M, Hartner A, Braun H, Kryzer C, Wang C, von Zglinicki T, Kränzlin B, GretzN, Melk A: Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 21: 327-336, 2010
109. ChengH, Fan X, LawsonWE, Paueksakon P, Harris RC: Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy. Kidney Int 88: 85-94, 2015
110. JaskelioffM, Muller FL, Paik J-H, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadiñanos J, Horner JW, Maratos-Flier E, Depinho RA: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469: 102-106, 2011
111. Ballermann BJ, Obeidat M: Tipping the balance from angiogenesis to fibrosis in CKD. Kidney Int Suppl (2011) 4: 45-52, 2014
112. Tanaka T, Kato H, Kojima I, Ohse T, Son D, Tawakami T, Yatagawa T, Inagi R, Fujita T, Nangaku M: Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci 61: 795-805, 2006
113. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601-611, 2001
114. Kramann R, Tanaka M, Humphreys BD: Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice. J Am Soc Nephrol 25: 1924-1931, 2014
115. Sebastián C, Espia M, Serra M, Celada A, Lloberas J: MacrophAging: A cellular and molecular review. Immunobiology 210: 121-126, 2005
116. Costa E, Fernandes J, Ribeiro S, Sereno J, Garrido P, Rocha-Pereira P, Coimbra S, Catarino C, Belo L, Bronze-da-Rocha E, Vala H, Alves R, Reis F, Santos-Silva A: Aging is associated with impaired renal function, INF-gamma induced inflammation and with alterations in iron regulatory proteins gene expression. Aging Dis 5: 356-365, 2013
117. Song F, Ma Y, Bai X-Y, Chen X: The expression changes of inflammasomes in the aging rat kidneys. JGerontol A Biol SciMed Sci 71: 747-756, 2015
118. StranksAJ, HansenAL, Panse I, MortensenM, Ferguson DJP, Puleston DJ, Shenderov K, Watson AS, VeldhoenM, Phadwal K, Cerundolo V, Simon AK: Autophagy controls acquisition of aging features in macrophages. J Innate Immun 7: 375-391, 2015
119. Zheng F, Cheng Q-L, Plati A-R, Ye SQ, Berho M, Banerjee A, Potier M, Jaimes EA, Yu H, Guan Y-F, Hao C-M, Striker LJ, Striker GE: The glomerulosclerosis of aging in females: Contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol 165: 1789-1798, 2004
120. Zhang B, Bailey WM, Braun KJ, Gensel JC: Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury. Exp Neurol 273: 83-91, 2015
121. Yang H-C, Rossini M, Ma L-J, Zuo Y, Ma J, Fogo AB: Cells derived from young bone marrow alleviate renal aging. J Am Soc Nephrol 22: 2028-2036, 2011
122. Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, Henderson JM, Ebert BL, Humphreys BD: Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16: 51-66, 2015
123. Humphreys BD, Lin S-L, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
124. Stefanska A, Eng D, KaverinaN, Duffield JS, Pippin JW, Rabinovitch P, Shankland SJ: Interstitial pericytes decrease in aged mouse kidneys. Aging (Albany, NY) 7: 370-382, 2015
125. Gomez IG, Duffield JS: The FOXD1 lineage of kidney perivascular cells and myofibroblasts: Functions and responses to injury. Kidney Int Suppl (2011) 4: 26-33, 2014
126. Schrimpf C, Teebken OE, Wilhelmi M, Duffield JS: The role of pericyte detachment in vascular rarefaction. J Vasc Res 51: 247-258, 2014
127. Rojas A, Chang F-C, Lin S-L, Duffield JS: The role played by perivascular cells in kidney interstitial injury. Clin Nephrol 77: 400-408, 2012
128. Lin S-L, Chang F-C, Schrimpf C, Chen Y-T, Wu C-F, Wu V-C, Chiang W-C, Kuhnert F, Kuo CJ, Chen Y-M, Wu K-D, Tsai T-J, Duffield JS: Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 178: 911-923, 2011
129. Chen Y-T, Chang F-C, Wu C-F, Chou Y-H, Hsu H-L, Chiang W-C, Shen J, Chen Y-M, Wu K-D, Tsai T-J, Duffield JS, Lin S-L: Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80: 1170-1181, 2011
130. Gagliano N, Arosio B, Santambrogio D, Balestrieri MR, Padoani G, Tagliabue J, Masson S, Vergani C, Annoni G: Agedependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex. J Gerontol A Biol Sci Med Sci 55: B365-B372, 2000
131. Lim K, Groen A, Molostvov G, Lu T, Lilley KS, Snead D, James S, Wilkinson IB, Ting S, Hsiao L-L, Hiemstra TF, ZehnderD: A-klotho expressison in human tissues. J Clin Endocrinol Metab 100: E1308-E1318, 2015
132. Keles N, Caliskan M, Dogan B, Keles NN, Kalcik M, Aksu F, Kostek O, Aung SM, Isbilen B, Oguz A: Low serumlevel of klotho is an early predictor of atherosclerosis. Tohoku J Exp Med 237: 17-23, 2015
133. Xu Y, Sun Z:Molecular basis of klotho: From gene to function in aging. Endocr Rev 36: 174-193, 2015
134. Arking DE, Krebsova A, Macek M Sr., Macek M Jr., Arking A, Mian IS, Fried L, Hamosh A, Dey S, McIntosh I, Dietz HC: Association of human aging with a functional variant of klotho. Proc Natl Acad Sci USA 99: 856-861, 2002
135. Nitta K, Nagano N, Tsuchiya K: Fibroblast growth factor 23/klotho axis in chronic kidney disease. Nephron Clin Pract 128: 1-10, 2014
136. Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP: Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin Oncol 12: 445-464, 2015
137. SpeeckaertMM, VanfraechemC, Speeckaert R, Delanghe JR: Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney. Ageing Res Rev 14: 1-18, 2014
138. Liu J, Wang LN: Peroxisome proliferatoractivated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Cochrane Database Syst Rev 1: CD010693, 2014
139. Duggan J, Kilfeather S, O'Brien E, O'Malley K, Nussberger J: Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density. Am J Hypertens 5: 687-693, 1992
140. Yoon HE, Choi BS: The renin-angiotensin system and aging in the kidney. Korean J Intern Med 29: 291-295, 2014
141. Panickar KS, Jewell DE: The beneficial role of anti-inflammatory dietary ingredients in attenuating markers of chronic low-grade inflammation in aging. Horm Mol Biol Clin Investig 23: 59-70, 2015
142. Vlassara H, Uribarri J, Ferrucci L, Cai W, TorreggianiM, Post JB, Zheng F, Striker GE: Identifying advanced glycation end products as a major source of oxidants in aging: Implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol 29: 594-603, 2009
143. Yubero-Serrano EM, Woodward M, Poretsky L, Vlassara H, Striker GE; AGE-less Study Group: Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. Clin J Am Soc Nephrol 10: 759-766, 2015
144. Halloran PF, Melk A, Barth C: Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am SocNephrol 10: 167-181, 1999
145. Melk A, Schmidt BMW, Vongwiwatana A, Rayner DC, Halloran PF: Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5: 1375-1382, 2005
146. Verzola D, Gandolfo MT, Gaetani G, Ferraris A, Mangerini R, Ferrario F, Villaggio B, Gianiorio F, Tosetti F, Weiss U, Traverso P, Mji M, Deferrari G, Garibotto G: Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295: F1563-F1573, 2008
147. Sis B, Tasanarong A, Khoshjou F, Dadras F, Solez K, Halloran PF: Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int 71: 218-226, 2007
148. Melk A, Schmidt BMW, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF: Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 65: 510-520, 2004
149. Melk A, Ramassar V, Helms LM, Moore R, Rayner D, Solez K, Halloran PF: Telomere shortening in kidneys with age. J Am Soc Nephrol 11: 444-453, 2000
150. Raschenberger J, Kollerits B, Titze S, Köttgen A, Bärthlein B, Ekici AB, Forer L, Schönherr S, Weissensteiner H, Haun M, Wanner C, Eckardt K-U, Kronenberg F; GCKD study Investigators: Association of relative telomere lengthwith cardiovascular disease in a large chronic kidney disease cohort: The GCKD study. Atherosclerosis 242: 529-534, 2015
151. Raschenberger J, Kollerits B, Ritchie J, Lane B, Kalra PA, Ritz E, Kronenberg F: Association of relative telomere length with progression of chronic kidney disease in two cohorts: Effect modification by smoking and diabetes. Sci Rep 5: 11887, 2015
152. Boxall MC, Goodship THJ, Brown AL, Ward MC, von Zglinicki T: Telomere shortening and haemodialysis. Blood Purif 24: 185-189, 2006
153. Epstein FH, Prasad P: Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 57: 2080-2083, 2000
154. Kasiske BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31: 1153-1159, 1987
155. Sarkar D, Fisher PB: Molecular mechanisms of aging-associated inflammation. Cancer Lett 236: 13-23, 2006
156. Costello-White R, Ryff CD, Coe CL: Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA. Age (Dordr) 37: 9808, 2015
157. BakerDJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM: Clearance of p16Ink4apositive senescent cells delays ageingassociated disorders. Nature 479: 232-236, 2011
158. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, van Deursen JM: BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36: 744-749, 2004
159. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA: Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764, 2005
160. Ruckh JM, Zhao J-W, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJM: Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10: 96-103, 2012
161. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park J-S, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, GalaskoDR, Xie XS, Rando TA, Wyss-Coray T: The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477: 90-94, 2011
162. Smith LK, He Y, Park J-S, Bieri G, Snethlage CE, Lin K, Gontier G, Wabl R, Plambeck KE, Udeochu J, Wheatley EG, Bouchard J, Eggel A, Narasimha R, Grant JL, Luo J, Wyss-Coray T, Villeda SA: B2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat Med 21: 932-937, 2015
163. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, Wojtkiewicz GR, Chen JW, Lee RT, Wagers AJ, Rubin LL: Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344: 630-634, 2014
164. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, Miller C, RegaladoSG, Loffredo FS, Pancoast JR, Hirshman MF, Lebowitz J, Shadrach JL, Cerletti M, Kim M-J, Serwold T, Goodyear LJ, Rosner B, Lee RT, Wagers AJ: Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344: 649-652, 2014
165. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, Sinha M, Dall'Osso C, KhongD, Shadrach JL, MillerCM, Singer BS, Stewart A, Psychogios N, Gerszten RE, Hartigan AJ, Kim M-J, Serwold T, Wagers AJ, Lee RT: Growth differentiation factor 11 is a circulating factor that reverses agerelated cardiac hypertrophy. Cell 153: 828-839, 2013
166. Smith SC, Zhang X, Zhang X, Gross P, Starosta T, Mohsin S, Franti M, Gupta P, Hayes D, Myzithras M, Kahn J, Tanner J, Weldon SM, Khalil A, Guo X, Sabri A, Chen X, MacDonnell S, Houser SR: GDF11 does not rescue aging-related pathological hypertrophy. Circ Res 117: 926-932, 2015
167. Rodgers BD, Eldridge JA: Reduced circulating GDF11 is unlikely responsible for age-dependent changes in mouse heart, muscle, and brain. Endocrinology 156: 3885-3888, 2015
168. Brun CE, Rudnicki MA: GDF11 and the mythical fountain of youth. Cell Metab 22: 54-56, 2015
169. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, Mallozzi C, Jacobi C, Jennings LL, Clay I, Laurent G, Ma S, Brachat S, Lach-Trifilieff E, Shavlakadze T, Trendelenburg A-U, Brack AS, Glass DJ: GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab 22: 164-174, 2015
170. Diep CQ, Ma D, Deo RC, Holm TM, Naylor RW, Arora N, Wingert RA, Bollig F, Djordjevic G, Lichman B, Zhu H, Ikenaga T, Ono F, Englert C, Cowan CA, Hukriede NA, Handin RI, Davidson AJ: Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 470: 95-100, 2011
171. Sander V, Davidson AJ: Kidney injury and regeneration in zebrafish. Semin Nephrol 34: 437-444, 2014
172. McKee RA, Wingert RA: Zebrafish renal pathology: Emerging models of acute kidney injury. Curr Pathobiol Rep 3: 171-181, 2015
173. Schrimpf C, Xin C, Campanholle G, Gill SE, Stallcup W, Lin S-L, Davis GE, Gharib SA, Humphreys BD, Duffield JS: Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 23: 868-883, 2012
174. Zhu Y, Tchkonia T, Pirtskhalava T, Gower A, Ding H, Giorgadze N, Palmer AK, Ikeno Y, Borden G, Lenburg M, O'Hara SP, LaRusso NF, Miller JD, Roos CM, Verzosa GC, LeBrasseur NK, Wren JD, Farr JN, Khosla S, StoutMB, McGowan SJ, Fuhrmann-Stroissnigg H, Gurkar AU, Zhao J, ColangeloD, Dorronsoro A, Ling YY, Barghouthy AS, Navarro DC, Sano T, Robbins PD, Niedernhofer LJ, Kirkland JL: The achilles' heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 14: 644-658, 2015
175. Pattaro C, Köttgen A, Teumer A, Garnaas M, Böger CA, Fuchsberger C, Olden M, Chen M-H, Tin A, Taliun D, Li M, Gao X, Gorski M, Yang Q, Hundertmark C, Foster MC, O'Seaghdha CM, Glazer N, Isaacs A, Liu C-T, Smith AV, O'Connell JR, Struchalin M, Tanaka T, Li G, Johnson AD, Gierman HJ, Feitosa M, Hwang S-J, Atkinson EJ, Lohman K, Cornelis MC, Johansson Å, Tönjes A, Dehghan A, Chouraki V, Holliday EG, Sorice R, Kutalik Z, Lehtimäki T, Esko T, Deshmukh H, Ulivi S, Chu AY, Murgia F, Trompet S, Imboden M, Kollerits B, Pistis G, Harris TB, Launer LJ, Aspelund T, Eiriksdottir G, Mitchell BD, Boerwinkle E, Schmidt H, Cavalieri M, Rao M, Hu FB, Demirkan A, Oostra BA, de Andrade M, Turner ST, Ding J, Andrews JS, Freedman BI, Koenig W, Illig T, Döring A, Wichmann H-E, Kolcic I, Zemunik T, Boban M, Minelli C, Wheeler HE, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Nöthlings U, Jacobs G, Biffar R, Endlich K, Ernst F, Homuth G, Kroemer HK, Nauck M, Stracke S, Völker U, Völzke H, Kovacs P, StumvollM, Mägi R, Hofman A, Uitterlinden AG, Rivadeneira F, Aulchenko YS, Polasek O, Hastie N, Vitart V, Helmer C, Wang JJ, Ruggiero D, Bergmann S, Kähönen M, Viikari J, Nikopensius T, Province M, Ketkar S, Colhoun H, Doney A, Robino A, Giulianini F, Krämer BK, Portas L, Ford I, Buckley BM, Adam M, Thun G-A, Paulweber B, Haun M, Sala C, Metzger M, Mitchell P, Ciullo M, Kim SK, Vollenweider P, RaitakariO, Metspalu A, Palmer C, Gasparini P, Pirastu M, Jukema JW, Probst-Hensch NM, Kronenberg F, Toniolo D, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Siscovick DS, van Duijn CM, Borecki I, Kardia SLR, Liu Y, Curhan GC, Rudan I, Gyllensten U, Wilson JF, Franke A, Pramstaller PP, Rettig R, Prokopenko I, Witteman JCM, Hayward C, Ridker P, Parsa A, Bochud M, Heid IM, Goessling W, Chasman DI, Kao WHL, Fox CS; CARDIoGRAM Consortium; ICBP Consortium; CARe Consortium; Wellcome Trust Case Control Consortium 2 (WTCCC2): Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 8: E1002584, 2012
176. Köttgen A, Glazer NL, Dehghan A, Hwang S-J, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen Y-DI, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Paré G, Ridker PM, Kao WHL, Witteman JC, Coresh J, Shlipak MG, Fox CS: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712-717, 2009
177. Gorski M, Tin A, Garnaas M, McMahon GM, Chu AY, Tayo BO, Pattaro C, Teumer A, Chasman DI, Chalmers J, Hamet P, Tremblay J, Woodward M, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Smith AV, Mitchell BD, O'Connell JR, Shuldiner AR, Coresh J, Li M, Freudenberger P, Hofer E, Schmidt H, Schmidt R, Holliday EG, Mitchell P, Wang JJ, de Boer IH, Li G, Siscovick DS, Kutalik Z, Corre T, Vollenweider P, Waeber G, Gupta J, Kanetsky PA, Hwang S-J, Olden M, Yang Q, de Andrade M, Atkinson EJ, Kardia SLR, Turner ST, Stafford JM, Ding J, Liu Y, Barlassina C, Cusi D, Salvi E, Staessen JA, Ridker PM, Grallert H, Meisinger C, Müller-Nurasyid M, Krämer BK, Kramer H, Rosas SE, Nolte IM, Penninx BW, Snieder H, Fabiola Del Greco M, Franke A, Nöthlings U, Lieb W, Bakker SJL, Gansevoort RT, van der Harst P, Dehghan A, Franco OH, Hofman A, Rivadeneira F, Sedaghat S, Uitterlinden AG, Coassin S, Haun M, Kollerits B, Kronenberg F, Paulweber B, Aumann N, Endlich K, Pietzner M, Völker U, Rettig R, Chouraki V, Helmer C, Lambert J-C, Metzger M, Stengel B, Lehtimäki T, Lyytikäinen L-P, Raitakari O, Johnson A, Parsa A, Bochud M, Heid IM, Goessling W, Köttgen A, Kao WHL, Fox CS, Böger CA: Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int 87: 1017-1029, 2015
178. Johnson SC, Dong X, Vijg J, Suh Y: Genetic evidence for common pathways in human age-related diseases. Aging Cell 14: 809-817, 2015
179. Tampe B, Zeisberg M: Contribution of genetics and epigenetics to progression of kidney fibrosis. Nephrol Dial Transplant 29 [Suppl 4]: Iv72-iv79, 2014
180. Noordmans GA, Hillebrands J-L, van Goor H, Korstanje R: A roadmap for the genetic analysis of renal aging. Aging Cell 14: 725-733, 2015
181. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T: Klotho: A tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27: 7094-7105, 2008
182. Bartke A: Long-lived klotho mice: New insights into the roles of IGF-1 and insulin in aging. Trends EndocrinolMetab 17: 33-35, 2006
183. Rodwell GEJ, Sonu R, Zahn JM, Lund J, Wilhelmy J, Wang L, Xiao W, Mindrinos M, Crane E, Segal E, Myers BD, Brooks JD, Davis RW, Higgins J, Owen AB, Kim SK: A transcriptional profile of aging in the human kidney. PLoS Biol 2: E427, 2004
184. Broer L, van Duijn CM: GWAS and metaanalysis in aging/longevity. Adv Exp Med Biol 847: 107-125, 2015
185. Plomin R, Haworth CMA, Davis OSP: Common disorders are quantitative traits. Nat Rev Genet 10: 872-878, 2009
186. TanQ, Zhao JH, Li S, Kruse TA, Christensen K: Power assessment for genetic association study of human longevity using offspring of long-lived subjects. Eur J Epidemiol 25: 501-506, 2010
187. Shi H, Belbin O, Medway C, Brown K, Kalsheker N, Carrasquillo M, Proitsi P, Powell J, Lovestone S, Goate A, Younkin S, Passmore P, Morgan K, CraigD, Johnston J, Mcguinness B, Todd S, Kehoe PG, Hooper NM, Vardy ERLC, Mann DM, Smith AD, Wilcock G, Warden D; Genetic and Environmental Risk for Alzheimer's Disease Consortium; Alzheimer's Research UK Consortium: Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging 33: 1849. e5-1849.e18, 2012
188. Rando TA, Chang HY: Aging, rejuvenation, and epigenetic reprogramming: Resetting the aging clock. Cell 148: 46-57, 2012
189. Dwivedi RS, Herman JG, McCaffrey TA, Raj DSC: Beyond genetics: Epigenetic code in chronic kidney disease. Kidney Int 79: 23-32, 2011
190. Reddy MA, Natarajan R: Epigenetics in diabetic kidney disease. J Am Soc Nephrol 22: 2182-2185, 2011
191. Smyth LJ, McKay GJ, Maxwell AP, McKnight AJ: DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics 9: 366-376, 2014
192. Trionfini P, Benigni A, Remuzzi G: Micro-RNAs in kidney physiology and disease. Nat Rev Nephrol 11: 23-33, 2015
193. Ben-Avraham D: Epigenetics of aging. Adv Exp Med Biol 847: 179-191, 2015
194. Canaud G, Bonventre JV: Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol Dial Transplant 30: 575-583, 2015
195. Hariri RJ, Hajjar DP, Coletti D, Alonso DR, Weksler ME, Rabellino E: Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol 131: 132-136, 1988
196. Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y, Yuan W: Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/b-catenin pathway. Cell Physiol Biochem 34: 2049-2060, 2014
197. Yonekura Y, Fujii H, Nakai K, Kono K, Goto S, Shinohara M, Nishi S: Anti-oxidative effect of the b-blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats [published online ahead of print July 14, 2015]. Clin Exp Pharmacol Physiol 10.1111/1440-1681.12447
198. Bianchessi V, Badi I, Bertolotti M, Nigro P, D'Alessandra Y, Capogrossi MC, Zanobini M, Pompilio G, Raucci A, Lauri A: The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells. J Mol Cell Cardiol 81: 62-70, 2015
199. LondonG, Covic A, Goldsmith D, Wiecek A, Suleymanlar G, Ortiz A, Massy Z, Lindholm B, Martinez-Castelao A, Fliser D, Agarwal R, Jager KJ, Dekker FW, Blankestijn PJ, Zoccali C; for EUropean REnal and CArdiovascular Medicine working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA): Arterial aging and arterial disease: Interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl (2011) 1: 10-12, 2011
200. Zeng Y, Wang P-H, ZhangM, Du J-R:Agingrelated renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-kB signaling pathway in senescence-accelerated mice. Aging Clin Exp Res 28: 69-76, 2015
201. Ren S, Duffield JS: Pericytes in kidney fibrosis. Curr Opin Nephrol Hypertens 22: 471-480, 2013